Skip to main content
. Author manuscript; available in PMC: 2014 Nov 4.
Published in final edited form as: Inorg Chem. 2013 May 24;52(21):10.1021/ic400295f. doi: 10.1021/ic400295f

Table 1.

Representative metalloproteins that are therapeutic targets.

Protein Cofactor Indication
Adamalysin Zn(II) Cancer
Angiotensin Converting Enzyme* Zn(II) Hypertension
Anthrax Lethal Factor Zn(II) Pathogen (Toxin)
Botulinum Neurotoxin Zn(II) Pathogen (Toxin)
Carbonic Anhydrase* Zn(II) Glaucoma
Farnesyltransferase Zn(II) Cancer
Histone Deacetlyase* Zn(II) Cancer
Matrix Metalloprotease* Zn(II) Cancer, Inflammation
Metallo-β-Lactamase Zn(II) Bacterial Infection
Neprilysin Zn(II) Hypertension
TNF-α Converting Enzyme Zn(II) Cancer
Lipoxygenase* Fe(II) Asthma
HIV Integrase* Mg(ll) Viral Infection
*

FDA-approved inhibitors exist for these metalloproteins